Sign Up to like & get
recommendations!
0
Published in 2021 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2021.113394
Abstract: Herein, we describe the design, synthesis, and structure-activity relationships of a series of imidazopyrrolopyridines derivatives that selectively inhibit Janus kinase 2 (JAK2). These screening cascades revealed that 6k was a preferred compound, with IC50 values…
read more here.
Keywords:
imidazopyrrolopyridines derivatives;
derivatives novel;
discovery imidazopyrrolopyridines;
novel selective ... See more keywords